Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: Pharmacoepidemiol Drug Saf. 2022 Jul 15;31(10):1056–1074. doi: 10.1002/pds.5506

Figure 1:

Figure 1:

Definition of exposure to chronic polypharmacy and potentially inappropriate medications (PIMs) in 2016. The exemple presented defined an individuals who is prevalent of PIMs and polypharmacy in 2016

PPI: Proton pump inhibitor; NSAID: Non-steroidal Anti-Inflammatory Drug